GSK will use promising results from two studies of its experimental chronic hepatitis B therapy to support planned regulatory ...

Hepatitis B is a virus that can damage the liver and lead to lifelong health problems. The hepatitis B vaccine prevents short ...

Federal health officials upended the immunization schedule for American children this week. These are the diseases affected.

GSK’s potential “functional cure” for hepatitis B drug has proven its worth in a pair of hotly anticipated phase 3 studies, ...

An advisory panel to the CDC voted to stop recommending hepatitis B shots at birth for most newborns. Why doctor says that's ...

The CDC's new vaccine schedule reduces recommended childhood vaccines from 17 to 11, impacting protection against diseases ...

Before the United States began vaccinating all infants at birth with the hepatitis B vaccine in 1991, around 18,000 children every year contracted the virus before their 10th birthday – about half of ...

The companies didn’t provide details, but said global regulatory filings are now planned for the therapy, an oligonucleotide ...

Though specific data for bepirovirsen remain under wraps, GSK plans to file for approval in the first quarter of 2026.

Thomas Jeffries does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

(CNN) — A group of independent vaccine advisers to the US Centers for Disease Control and Prevention is meeting this week, and a key item on the agenda is the hepatitis B vaccine. After presentations ...

Hepatitis B is a virus that can damage the liver and lead to lifelong health problems. The hepatitis B vaccine prevents short ...